Photo from academic.microsoft.com
Sign Up to like & get
recommendations!
0
Published in 2017 at "British Journal of Surgery"
DOI: 10.1002/bjs.10576
Abstract: Recent observations have suggested a decline in vulnerable carotid artery and iliofemoral atherosclerotic plaque characteristics over the past decade. The aim of this study was to determine whether, in the presence of clinically manifest carotid…
read more here.
Keywords:
cardiovascular adverse;
trends cardiovascular;
events follow;
dependent trends ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2024 at "Cancer Medicine"
DOI: 10.1002/cam4.7233
Abstract: Over the past decade, immune checkpoint inhibitors (ICIs) have significantly transformed cancer treatment. However, ICIs inevitably may cause a spectrum of immune‐related adverse events, among which cardiovascular toxicity, particularly myocarditis, while infrequent, has garnered increasing…
read more here.
Keywords:
cardiovascular adverse;
adverse events;
immune checkpoint;
events associated ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2024 at "International Journal of Geriatric Psychiatry"
DOI: 10.1002/gps.70018
Abstract: The aim of this study was to conduct a comparative analysis of the proportion of cardiovascular adverse events (AEs) associated with the utilization of memantine and cholinesterase inhibitors and to highlight the potential impact of…
read more here.
Keywords:
cardiovascular adverse;
adverse events;
sex differences;
memantine cholinesterase ... See more keywords
Photo from academic.microsoft.com
Sign Up to like & get
recommendations!
0
Published in 2018 at "Journal of Clinical Laboratory Analysis"
DOI: 10.1002/jcla.22369
Abstract: This study was aimed to investigate the correlation between CYP2C19 and ABCB1 polymorphisms and the recurrence of ischemic cardiovascular adverse events in patients with coronary artery disease treated with clopidogrel.
read more here.
Keywords:
recurrence ischemic;
cardiovascular adverse;
cyp2c19 abcb1;
adverse events ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2018 at "Cancer Chemotherapy and Pharmacology"
DOI: 10.1007/s00280-018-3593-9
Abstract: PurposeCancer chemotherapies have improved the prognosis of cancer patients in recent years; however, their side effects on the cardiovascular systems have emerged as a major concern in the field of both cardiology and oncology. In…
read more here.
Keywords:
cardiovascular adverse;
sunitinib;
cardiac troponin;
adverse events ... See more keywords
Photo from wikipedia
Sign Up to like & get
recommendations!
1
Published in 2020 at "International journal of cardiology"
DOI: 10.1016/j.ijcard.2020.03.025
Abstract: BACKGROUND Recent randomized control trials have described a protective cardiovascular effect of novel glucose lowering drugs in patients at high cardiovascular risk. Whether these second-line agents have similar effects in the general population is unknown.…
read more here.
Keywords:
second line;
cardiovascular adverse;
risk;
novel glucose ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2025 at "Scientific Reports"
DOI: 10.1038/s41598-025-20999-3
Abstract: Anaphylaxis is a life-threatening hypersensitivity reaction requiring prompt administration of epinephrine. Despite its life-saving role, hesitancy in epinephrine use persists, largely due to concerns about cardiovascular adverse events (AEs). This study aimed to characterize potentially…
read more here.
Keywords:
cardiovascular aes;
cardiovascular adverse;
adverse events;
epinephrine ... See more keywords
Photo from wikipedia
Sign Up to like & get
recommendations!
0
Published in 2021 at "Expert opinion on drug safety"
DOI: 10.1080/14740338.2021.1965988
Abstract: INTRODUCTION Non-steroidal anti-inflammatory drugs (NSAIDs) are one of the most prescribed pharmacological groups, especially in elderly patients.Areas Covered: The main GI and CV adverse events associated with NSAID use are reviewed. Risk factors and prophylactic…
read more here.
Keywords:
cardiovascular adverse;
upper lower;
cox selective;
events associated ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2019 at "Journal of Internal Medicine"
DOI: 10.1111/joim.12882
Abstract: The novel proteasome inhibitor carfilzomib alone or in combination with other agents is already one of the standard therapies for relapsed and/or refractory multiple myeloma (MM) patients and produces impressive response rates in newly diagnosed…
read more here.
Keywords:
cardiovascular adverse;
myeloma;
treatment;
myeloma patients ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2025 at "Journal of Clinical Oncology"
DOI: 10.1200/jco.2025.43.16_suppl.e24025
Abstract: e24025 Background: With the expansion of Chimeric Antigen Receptor T-Cell (CAR-T) Therapy in hematologic malignancies, significant treatment adverse effects have been observed. The exploration of cardiovascular effects has been limited due to a paucity in…
read more here.
Keywords:
cardiovascular adverse;
therapy;
adverse effects;
car therapy ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2017 at "Revista da Associacao Medica Brasileira"
DOI: 10.1590/1806-9282.63.03.261
Abstract: Objective: Determine whether there is an association between the risk of cardiovascular adverse events and the use of antipsychotic agents. Method: Analysis of original articles retrieved from the following databases: LILACS, PubMed, Cochrane Controlled Trials…
read more here.
Keywords:
events systematic;
cardiovascular adverse;
association antipsychotics;
adverse events ... See more keywords